Accessibility Menu
Medartis Ag logo

Medartis Ag(OTC) MDRSF

Market Cap$1.43BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)+141%
5 Year+95%
1 Year+122%
1 Month+0%
$115.00
+0.00%
+0.00Today
Medartis Ag last closing stock price
MetricPriceDate
Last closeUSD 115.002026-07-13
Medartis Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 115.002026-04-24
1 month+0%USD 115.002026-04-24
3 month+0%USD 115.002026-04-10
Year to date+15%USD 100.002025-10-27
1 year+122.44%USD 51.702024-11-19
3 year+47.51%USD 77.962023-05-22
5 year+94.92%USD 59.002021-05-18
Since inception+140.84%USD 47.752020-01-17

Medartis Ag Financials at a Glance

Market Cap

$1.43BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CHF 494.16M

Net Income (TTM)

CHF 11.88M

EPS (TTM)

$0.85

P/E Ratio

135.31

Dividend

$0.00

Beta (Volatility)

0.02 (Low)

Price

$115.00

Volume

100

Open

$115.00

Previous Close

$115.00

Daily Range

$115.00 - $115.00

52-Week Range

$100.00 - $115.00

Estimated Earnings Date

Aug 18, 2026

MDRSF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Medartis Ag

Medartis Holding AG is a Switzerland-based medical technology firm, founded in 1997 and headquartered in Basel. The company specializes in the global creation, production, and distribution of advanced implant solutions for surgical repair and stabilization of bone fractures.

Products and Services
  • Advanced implant solutions for bone fractures
  • Osteosynthesis instruments under APTUS and MODUS brands
  • Medical devices for upper and lower limb surgeries
Growth Outlook
  • Revenue of 146.3 million CHF in Q4 2025, a significant increase
  • Gross profit margin of 72.8% in Q4 2025, indicating strong profitability
  • Operating income improved to -8.16 million CHF in Q4 2025 from -4.27 million CHF in Q2 2025
Financial Highlights
  • Net income of 9.8 million CHF in Q4 2025, showcasing recovery
  • Current ratio of 2.21, indicating strong liquidity position
  • Cash flow from operations of 24.2 million CHF in Q4 2025, reflecting operational efficiency
Medartis Holding AG operates in the medical devices sector, focusing on innovative solutions for complex surgical procedures. The company has demonstrated resilience and growth potential, particularly in its recent financial performance. The increase in revenue and gross profit margin highlights the effectiveness of its product offerings and market strategy. The strong liquidity position, as indicated by the current ratio, suggests that the company is well-equipped to manage its short-term obligations. Overall, Medartis presents a compelling opportunity for investors interested in the healthcare technology sector.
AI Generated • Jul 22, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

1,337

CEO

Matthias Schupp

Website

www.medartis.com

Headquarters

Basel, BS 4057, CH

MDRSF Financials

Key Financial Metrics (TTM)

Gross Margin

75.89%

Operating Margin

0.42%

Net Income Margin

3.10%

Return on Equity

3.11%

Return on Capital

0.45%

Return on Assets

1.49%

Earnings Yield

0.74%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.43BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

12.45M

Volume

100

Avg. Volume

1.587

Financials (TTM)

Gross Profit

CHF 383.06M

Operating Income

CHF 8.99M

EBITDA

CHF 55.78M

Operating Cash Flow

CHF 64.90M

Capital Expenditure

-CHF 29.77M

Free Cash Flow

CHF 35.13M

Cash & ST Invst.

CHF 32.97M

Total Debt

CHF 157.72M

Medartis Ag Performance Analysis

Medartis Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CHF 191,426,1299.5%
20232023-12-31CHF 235,915,63723.2%
20242024-12-31CHF 255,296,1058.2%
20252025-12-31CHF 324,216,08827.0%
Medartis Ag sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-302.5%
Q42024-12-311.6%
Q22025-06-308.6%
Q42025-12-3118.9%
Medartis Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CHF -0.51N/A
20232023-12-31CHF 0.06N/A
20242024-12-31CHF 0.32473.5%
20252025-12-31CHF 0.81150.1%
Medartis Ag sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-3058.3%
Q42024-12-31-63.2%
Q22025-06-30-271.4%
Q42025-12-31758.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

CHF 146.29M

+34.5%

Gross Profit

CHF 106.54M

+21.3%

Gross Margin

72.83%

N/A

Market Cap

$1.43BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.75M

N/A

Employees

816

N/A

Net Income

CHF 9.80M

+568.3%

EBITDA

CHF 5.61M

-68.4%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

CHF 32.97M

+30.8%

Total Debt

CHF 157.72M

+274.0%

Accounts Receivable

CHF 58.98M

+27.2%

Inventory

CHF 98.20M

+43.8%

Long Term Debt

CHF 131.54M

+271.5%

Short Term Debt

CHF 26.18M

+287.3%

Return on Assets

1.49%

N/A

Return on Invested Capital

0.24%

N/A

Free Cash Flow

CHF 11.50M

-11.9%

Operating Cash Flow

CHF 24.19M

+5.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BITGFBiotage AB (publ)
$15.01+0.00%
DGWPFDrägerwerk AG & Co. KGaA
$93.00+12.05%
SSIISS Innovations International, Inc.
$3.98-0.25%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About MDRSF

What is the current price of Medartis Ag?

Medartis Ag is trading at $115.00 per share.

What is the 52-week range for Medartis Ag?

Over the past 52 weeks, Medartis Ag has traded between $100.00 and $115.00.

How much debt does Medartis Ag have?

As of the most recent reporting period, Medartis Ag reported total debt of CHF 199.58M.

How much cash does Medartis Ag have on hand?

Medartis Ag reported CHF 41.61M in cash and cash equivalents in its most recent financial results.

What is Medartis Ag’s dividend yield?

Medartis Ag does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services